MacLean Michael F
SEC insider (Form 3/4/5 filer). CIK 0001383731. Director at Research Alliance Corp III (RACC) and 3 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in CAMBRIDGE, MA.
Companies MacLean Michael F has filed insider reports for
- Research Alliance Corp III (RACC): Director
- Camp4 Therapeutics Corp (CAMP): Director
- Avidity Biosciences, Inc. (RNAM): Officer, Chief Financial Officer
- Verve Therapeutics, Inc. (VERV): Director
MacLean Michael F
CIK: 0001383731
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Apr 1, 2026CAMP
Camp4 Therapeutics Corp
AwardDirectStock Option (Right to Buy)
56K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionDirect134K shares- - Jan 21, 2026RNA
Avidity Biosciences, Inc.
SaleDirect1.8K shares at avg. $72.45$131K - Jan 21, 2026RNA
Avidity Biosciences, Inc.
SaleDirect2.7K shares at avg. $72.45$198K - Jan 7, 2026RNA
Avidity Biosciences, Inc.
SaleDirect2K shares at avg. $72.23$143K - Aug 6, 2025RNA
Avidity Biosciences, Inc.
SaleDirect30.9K shares at avg. $42.73$1.3M - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
136.1K shares- - Jun 5, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
42.2K shares- - Mar 20, 2025RNA
Avidity Biosciences, Inc.
SaleDirect7.9K shares at avg. $31.06$246K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 |  CAMP Camp4 Therapeutics Corp | Award Stock Option (Right to Buy) | 56,000 | - | - | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition | 133,977 | - | $0 | Direct |
| Jan 21, 2026 |  RNA Avidity Biosciences, Inc. | Sale | 1,807 | $72.45 | $130,917 | Direct |
| Jan 21, 2026 | RNA Avidity Biosciences, Inc. | Sale | 2,735 | $72.45 | $198,151 | Direct |
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | Sale | 1,974 | $72.23 | $142,582 | Direct |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | Sale | 30,914 | $42.73 | $1,320,844 | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 136,139 | - | - | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 42,200 | - | - | Direct |
| Mar 20, 2025 | RNA Avidity Biosciences, Inc. | Sale | 7,935 | $31.06 | $246,425 | Direct |
1-10 of 22 transactions